These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32622691)

  • 1. Association of conflicting information from healthcare providers and poor shared decision making with suboptimal adherence in direct oral anticoagulant treatment: A cross-sectional study in patients with atrial fibrillation.
    Moudallel S; van den Bemt BJF; Zwikker H; de Veer A; Rydant S; Dijk LV; Steurbaut S
    Patient Educ Couns; 2021 Jan; 104(1):155-162. PubMed ID: 32622691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
    Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
    Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation.
    Smet L; Heggermont WA; Goossens E; Eeckloo K; Vander Stichele R; De Potter T; De Backer T
    J Adv Nurs; 2018 Nov; 74(11):2577-2587. PubMed ID: 29944735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between medication adherence and illness perceptions in atrial fibrillation patients treated with direct oral anticoagulants: An observational cross-sectional pilot study.
    Miyazaki M; Nakashima A; Nakamura Y; Sakamoto Y; Matsuo K; Goto M; Uchiyama M; Okamura K; Mitsutake R; Urata H; Kamimura H; Imakyure O
    PLoS One; 2018; 13(9):e0204814. PubMed ID: 30265710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adherence, treatment satisfaction and knowledge of direct oral anticoagulants in atrial fibrillation patients.
    Moudallel S; van Laere S; Cornu P; Dupont A; Steurbaut S
    Br J Clin Pharmacol; 2022 May; 88(5):2419-2429. PubMed ID: 34907577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study.
    Gulpen AJW; Braeken DCW; Schalla S; Ten Cate H; Crijns HJ; Ten Cate-Hoek AJ
    Acta Haematol; 2022; 145(5):476-483. PubMed ID: 35306490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation.
    Rolls CA; Obamiro KO; Chalmers L; Bereznicki LRE
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28869793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants and therapeutic adherence: do not let your guard down.
    Di Gennaro L; Monaco M; Riccio C; De Candia E; Alberelli MA; di Martino C; Basso M; Ferretti MA; Lancellotti S; De Cristofaro R
    Acta Cardiol; 2022 May; 77(3):243-249. PubMed ID: 33896375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription frequency and predictors for the use of novel direct oral anticoagulants for secondary stroke prevention in the first year after their marketing in Europe--a multicentric evaluation.
    Luger S; Hohmann C; Kraft P; Halmer R; Gunreben I; Neumann-Haefelin T; Kleinschnitz C; Walter S; Haripyan V; Steinmetz H; Foerch C; Pfeilschifter W
    Int J Stroke; 2014 Jul; 9(5):569-75. PubMed ID: 24828272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
    Pandya E; Bajorek BV
    J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.
    Borne RT; O'Donnell C; Turakhia MP; Varosy PD; Jackevicius CA; Marzec LN; Masoudi FA; Hess PL; Maddox TM; Ho PM
    BMC Cardiovasc Disord; 2017 Sep; 17(1):236. PubMed ID: 28865440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey.
    Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):337-343. PubMed ID: 29658327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study.
    Salmasi S; Safari A; Kapanen A; Adelakun A; Kwan L; MacGillivray J; Andrade JG; Deyell MW; Loewen P
    Res Social Adm Pharm; 2022 Nov; 18(11):3920-3928. PubMed ID: 35753963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation.
    Perreault S; de Denus S; White-Guay B; Côté R; Schnitzer ME; Dubé MP; Dorais M; Tardif JC
    Pharmacotherapy; 2020 Jan; 40(1):40-54. PubMed ID: 31758592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of treatment adherence with direct oral anticoagulants in pandemic.
    Dittrich T; Polymeris A; De Marchis GM
    Curr Opin Neurol; 2021 Feb; 34(1):38-44. PubMed ID: 33230038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
    Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
    Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation.
    Brais C; Larochelle J; Turgeon MH; Blais L; Farand P; Perreault S; Letemplier G; Beauchesne MF
    J Pharm Pharm Sci; 2017; 20():8-14. PubMed ID: 28459661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.